Tate Michael Truett 4

What Happened Tate Michael Truett, Chief Financial Officer of Astera Labs (ALAB), disposed of 12,001 shares in multiple open-market transactions on February 17, 2026, generating total gross proceeds of $1,485,784. Breakdown by lot:

• 753 shares @ $122.16 = $91,984
• 4,250 shares @ $122.84 = $522,086
• 3,556 shares @ $123.93 = $440,690
• 2,281 shares @ $124.66 = $284,343
• 1,161 shares @ $126.34 = $146,681

Per the filing footnotes, these were disposals (reported as "S" for sale) but at least some were automatic "sell-to-cover" transactions to satisfy tax withholding obligations tied to the vesting/settlement of previously granted restricted stock units (RSUs), and thus were not discretionary sales by the CFO.

Key Details

• Transaction date: February 17, 2026. Filing date: February 19, 2026 (filed within typical 2-business-day Form 4 window — appears timely).
• Total shares sold: 12,001; total proceeds: $1,485,784.
• Price ranges (per footnotes): groups of shares sold at weighted-average prices with ranges roughly $122.10–$126.34 across the lots (see footnotes F2–F5 for specific subranges and weighted-average details).
• Footnote F1: indicates shares were required to be sold to satisfy tax withholding on RSU vesting ("sell-to-cover").
• Footnote F6: some shares referenced are held by the Tate 1997 Living Trust; the reporting person disclaims beneficial ownership except for any pecuniary interest.
• Shares owned after the transactions are not specified in the provided excerpt of the filing.

Context "Sell-to-cover" sales are routine tax-withholding transactions tied to equity awards and do not necessarily reflect the insider's discretionary view of the company. For retail investors, purchases or direct discretionary sales may be more informative about insider sentiment; this filing primarily documents automated tax-related disposals. The filing does not indicate a 10b5-1 plan or other trading program.